RT @Oncotarget: #PaperoftheDay: "UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology" DOI: https://t.co/6v3GA7ghn8 #…
#PaperoftheDay: "UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology" DOI: https://t.co/6v3GA7ghn8 #cancerresearch #oncology #MedEd
Watch an #oncotargetshort video on this #trendingwithimpact review #published on September 28, entitled, “UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology." @HopkinsMedicine @DukeHealth @StanfordEpiNews https://t.co/6v3GA7ghn8 #c
RT @DukeMets: NEW in @OncotargetJrnl: @Dukeneurosurg and @DukeCancer researchers classify UGDH enzyme as an indicator of tumor progression…
Researchers from @DukeCancer @Duke_PCB @Dukeneurosurg classified the UGDH enzyme as a molecular indicator of tumor progression in multiple cancer types & as a potential therapeutic target. @DukeMets Surgical Dir. Rory Goodwin, MD, PhD, is senior author
RT @DukeMets: NEW in @OncotargetJrnl: @Dukeneurosurg and @DukeCancer researchers classify UGDH enzyme as an indicator of tumor progression…
RT @DukeMets: NEW in @OncotargetJrnl: @Dukeneurosurg and @DukeCancer researchers classify UGDH enzyme as an indicator of tumor progression…
RT @DukeMets: NEW in @OncotargetJrnl: @Dukeneurosurg and @DukeCancer researchers classify UGDH enzyme as an indicator of tumor progression…
RT @DukeMets: NEW in @OncotargetJrnl: @Dukeneurosurg and @DukeCancer researchers classify UGDH enzyme as an indicator of tumor progression…
RT @DukeMets: NEW in @OncotargetJrnl: @Dukeneurosurg and @DukeCancer researchers classify UGDH enzyme as an indicator of tumor progression…
RT @DukeMets: NEW in @OncotargetJrnl: @Dukeneurosurg and @DukeCancer researchers classify UGDH enzyme as an indicator of tumor progression…
NEW in @OncotargetJrnl: @Dukeneurosurg and @DukeCancer researchers classify UGDH enzyme as an indicator of tumor progression and a possible target for treatment. DCBSM surgical director Rory Goodwin, MD, PhD is the senior author. https://t.co/g2lwefDzlr ht
#TrendingWithImpact: On September 28, 2023, researchers from @HopkinsMedicine, @DukeU, @Stanford, @Dukeneurosurg, and @dukecancer published a new review paper in #Oncotarget: “UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology.” DOI:
Watch an #oncotargetshort video on this #trendingwithimpact review #published on September 28, entitled, “UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology." @HopkinsMedicine @DukeHealth @StanfordEpiNews https://t.co/6v3GA7ghn8 #c
RT @Oncotarget: NEW #PaperoftheDay: "UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology" DOI: https://t.co/6v3GA7ghn…
NEW #PaperoftheDay: "UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology" DOI: https://t.co/6v3GA7ghn8 #cancerresearch #oncology #OA #MedEd